Market closed
Access this stock data via API
Subscribe
OncoTherapy Science Inc.
0
0
0%

Financials

Income statement

Fiscal date 2025 2024 2023 2022
Total reported revenue 750.0M 610.1M 1.1B 1.2B
Cost of revenue 762.8M 787.8M 1.1B 1.0B
Gross profit -12.8M -177.7M 41.7M 113.9M
Operating expense
Research & development 491.1M 678.1M 716.5M 1.7B
Selling general and admin 294.1M 265.0M 431.6M 436.3M
Other operating expenses
Operating income -797.9M -1.1B -1.1B -2.1B
Non operating interest income
Income 751K 19K 218K 430K
Expense 1.2M 218K 0
Other income expense
Pretax income -813.1M -1.3B -1.1B -2.6B
Tax provision 2.2M 2.4M 2.2M 1.2M
Net income -815.3M -1.3B -1.1B -2.6B
Basic EPS -3.1 -6.1 -5.8 -13.7
Diluted EPS -3.1 -6.1 -5.8 -13.7
Basic average shares 261.1M 212.8M 192.6M 187.5M
Diluted average shares 261.1M 212.8M 192.6M 187.5M
EBITDA -813.8M -1.1B -1.1B -1.5B
Net income from continuing op. -813.1M -1.3B -1.1B -2.6B
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 12 hours 54 minutes

20:05
00:00
09:00
15:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 15:30
All times are displayed in the Asia/Tokyo timezone (JST, UTC+09:00).